Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00792259 · ClinicalTrials.gov registry record
Topcon 3D OCT-1000 Optical Coherence Tomography System
A clinical trial of Glaucoma and Retinal Disease, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 48
- Enrollment target
- 4
- Study locations
NCT00792259: Completed study of Glaucoma and Retinal Disease, sponsored by Topcon Medical Systems.
NCT00792259 is a study of Glaucoma and Retinal Disease that has completed, run by Topcon Medical Systems. The registered enrollment target is 48 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00792259, a study of Glaucoma and Retinal Disease, has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this clinical protocol is to perform a comparison of Retinal and Retinal Nerve Fiber Layer (RNFL) thickness measurements between the Topcon 3D-1000 and the identified predicate device. In addition, this protocol performs a comparison of the thickness measurement results from images collected and analyzed with the Zeiss Stratus OCT to images collected with the Zeiss Stratus OCT and imported into the Topcon 3D OCT-1000 StratusViewer for analysis.
Primary Outcome
The precision and agreement measures the thickness of RNFL and Full Retinal Thickness of the study device and is compared to the predicate device to show agreement. Keywords, ILM - Internal Limiting Membrane RPE - Retinal Pigment Epithelium RNFL - Retinal Nerve Fiber Layer
Conditions Studied
Study Locations (4)
New York
- Retina Consultations - Bronxville
- New York Eye and Ear-Glaucoma Associates of New York - New York
- Vitreous-Retina-Macula Consultants of NY - New York
- SUNY - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2008-10 |
| Est. Completion | 2008-11 |
What the finished NCT00792259 record still lists
NCT00792259 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 0 interventions.
NCT00792259 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00792259 about?
NCT00792259 is a clinical study titled "Topcon 3D OCT-1000 Optical Coherence Tomography System". The purpose of this clinical protocol is to perform a comparison of Retinal and Retinal Nerve Fiber Layer (RNFL) thickness measurements between the Topcon 3D-1000 and the identified predicate device. In addition, this protocol performs a comparison of the thickness measurement results from images co...
What is the current status of trial NCT00792259?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2008-10. Estimated completion is 2008-11.
What conditions does trial NCT00792259 study?
This clinical trial studies the following conditions: Glaucoma, Retinal Disease.
Who is sponsoring clinical trial NCT00792259?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00792259 being conducted?
This trial has 4 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00792259's enrollment target sits among peer trials
48 67th of 92 higher than 25 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Eye Pressure Lowering Surgery
RECRUITING
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia